Hossein Hatami

Hossein Hatami

Auto-generated profile, based on publicly available information

Hossein Hatami

Department of Public Health, School of Public Health and Safety and Occupational Hazards Control Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
HHHossein Hatami
Hossein Hatami
PJParnian Jamshidi
Parnian Jamshidi
MAMahta Arbabi
Mahta Arbabi
SSSeyed Amir Ahmad Safavi-Naini
Seyed Amir Ahmad Safavi-Naini
PFParisa Farokh
Parisa Farokh
Leonardo SechiLeonardo Sechi
Leonardo Sechi
(1) Background: In early May 2022, an increasing number of human monkeypox (mpox) cases were reported in non-endemic disparate regions of the world, which raised concerns. Here, we provide a systematic review and meta-analysis of mpox-confirmed patients presented in peer-reviewed publications over the 10 years before and during the 2022 outbreak from demographic, epidemiological, and clinical perspectives. (2) Methods: A systematic search was performed for relevant studies published in Pubmed/Medline, Embase, Scopus, and Google Scholar from 1 January 2012 up to 15 February 2023. Pooled frequencies with 95% confidence intervals (CIs) were assessed using the random or fixed effect model due to the estimated heterogeneity of the true effect sizes. (3) Results: Out of 10,163 articles, 67 met the inclusion criteria, and 31 cross-sectional studies were included for meta-analysis. Animal-to-human transmission was dominant in pre-2022 cases (61.64%), but almost all post-2022 reported cases had a history of human contact, especially sexual contact. The pooled frequency of MSM individuals was 93.5% (95% CI 91.0–95.4, I2: 86.60%) and was reported only in post-2022 included studies. The male gender was predominant in both pre- and post-2022 outbreaks, and the mean age of confirmed cases was 29.92 years (5.77–41, SD: 9.38). The most common clinical manifestations were rash, fever, lymphadenopathy, and malaise/fatigue. Proctalgia/proctitis (16.6%, 95% CI 10.3–25.6, I2: 97.76) and anal/perianal lesions (39.8%, 95% CI 30.4–49.9, I2: 98.10) were the unprecedented clinical manifestations during the 2022 outbreak, which were not described before. Genitalia involvement was more common in post-2022 mpox patients (55.6%, 95% CI 51.7–59.4, I2: 88.11). (4) Conclusions: There are speculations about the possibility of changes in the pathogenic properties of the virus. It seems that post-2022 mpox cases experience a milder disease with fewer rashes and lower mortality rates. Moreover, the vast majority of post-2022 cases are managed on an outpatient basis. Our study could serve as a basis for ongoing investigations to identify the different aspects of previous mpox outbreaks and compare them with the current ones.

30 April 2022 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
HHHossein Hatami1
Hossein Hatami1
Giovanni SotgiuGiovanni Sotgiu
Giovanni Sotgiu
NBNarjess Bostanghadiri3
Narjess Bostanghadiri3
SASahel Shafiee Dolat Abadi4
Sahel Shafiee Dolat Abadi4
BMBita Mesgarpour
Bita Mesgarpour
Mohammad Javad NasiriMohammad Javad Nasiri
Mohammad Javad Nasiri
Objective: Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening infectious disease. Treatment requires multiple antimicrobial agents used for extended periods of time. The present study sought to evaluate the treatment success rate of bedaquiline-based regimens in MDR-TB patients. Methods: This was a systematic review and meta-analysis of studies published up to March 15, 2021. The pooled treatment success rates and 95% CIs were assessed with the fixed-effect model or the random-effects model. Values of p < 0.05 were considered significant for publication bias. Results: A total of 2,679 articles were retrieved by database searching. Of those, 29 met the inclusion criteria. Of those, 25 were observational studies (including a total of 3,536 patients) and 4 were experimental studies (including a total of 440 patients). The pooled treatment success rate was 74.7% (95% CI, 69.8-79.0) in the observational studies and 86.1% (95% CI, 76.8-92.1; p = 0.00; I2 = 75%) in the experimental studies. There was no evidence of publication bias (p > 0.05). Conclusions: In patients with MDR-TB receiving bedaquiline, culture conversion and treatment success rates are high even in cases of extensive resistance.

1 June 2008 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
BSBatool Sharifi-Mood
Batool Sharifi-Mood
MMMasoud Mardani
Masoud Mardani
MJMaryam Keshtkar Jahromi
Maryam Keshtkar Jahromi
MRMohammad Rahnavardi
Mohammad Rahnavardi
HHHosein Hatami
Hosein Hatami
MMMalihe Metanat
Malihe Metanat
This study aimed to investigate the clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among 34 children and adolescents (mean age, 13.3 ± 4.6 years) from a highly endemic region. Clinical manifestations were similar to those in adults. The case-fatality ratio was 26.5% (9 of 34). Compared with adult patients, children and adolescents may be more vulnerable to severe and fatal Crimean-Congo hemorrhagic fever.

17 December 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MMMohammad Sadegh Adel Mehraban
Mohammad Sadegh Adel Mehraban
MSMeysam Shirzad
Meysam Shirzad
LKLeila Mohammad Taghizadeh Kashani
Leila Mohammad Taghizadeh Kashani
MAMohammad Mahdi Ahmadian-Attari
Mohammad Mahdi Ahmadian-Attari
ASAli Akbar Safari
Ali Akbar Safari
MKMohammad Kamalinejad
Mohammad Kamalinejad

5 January 2013 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
HHHossein Hatami
Hossein Hatami
MSMasoud Salehi
Masoud Salehi
ESEsmail Sanei
Esmail Sanei
SKSoheila Khosravi
Soheila Khosravi
SASeyed Moayed Alavian
Seyed Moayed Alavian
Background: The household transmission of hepatitis B virus (HBV) is a major health problem. The prevalence rate of this infection is reported about 11% to 57% among family members of HBsAg carriers. Objectives: This study was conducted to evaluate serological determinants of chronic hepatitis B infection, especially HBsAg positivity, among family members of asymptomatic HBsAg positive carriers in Zahedan (Southeast of Iran). Patients and Methods: In a cross-sectional study, data were collected from the total number of 454 HBsAg positive cases and 1817 members of their family by trained interviewers and a validated questionnaire. In addition, blood samples were obtained and titrated to detect serologic markers of hepatitis B. All subjects were recruited following informed consent to the study. Results: In total, 454 chronic HBsAg carriers (66% male) with mean age of 36 ± 10 years and 1817 of their family members were included in the study. The prevalence rate of HBsAg and HBcAb positivity among household members were 19.3% (n = 351) and 51% (n = 573), respectively. The frequency of HBV markers was different by age groups. The highest prevalence rate of HBsAg (34.9%) and HBcAb (31.9%) positivity were found in the age group of 21-30 years old. Importantly, the mothers of index cases had the highest prevalence of HBsAg positivity compared to their spouses who had the lowest proportion (53.2% vs. 8.4%, P < 0.001). Conclusions: In family members, HBsAg positivity was four times greater than the general indigenous population. Considering the importance of close contacts for transmission, it was more prevalent in mothers of index cases compared to their spouses, suggesting more efficient mother-to-child than sexually transmission of HBV. It was also more prevalent in those having a history of hepatitis B in their maternal family compared to those with paternal one, probably due to more efficient transmission from infected mothers to children. The lower prevalence of HBsAg positivity in lower age groups could be attributed to vaccination of Iranian infants since 1993 and the screening of HBsAg positive mothers during the last two decades. Keywords: Carrier States; Hepatitis B; Transmission; Iran; Prevention and control; HBV Seroprevalence

1 January 2013
Verified
Journal Article
Open access
NFN Fahimfar
N Fahimfar
ASA Sedaghat
A Sedaghat
HHH Hatami
H Hatami
KKK Kamali
K Kamali
MGMm Gooya
Mm Gooya
Human immunodeficiency virus (HIV) is a public health challenge facing both developing and developed nations. Although injecting drug use is even the main route of HIV transmission in Iran, sexual route is rising gradually. Vulnerable women have been considered as important bridging population for driving HIV epidemics. To increase the access to vulnerable women, in 2007, 5 pilot centers were established in risky areas to deliver comprehensive services to women who themselves or their spouses are engaged in drug use, risky sexual behavior or have history of imprisonment. Management of Sexually Transmitted Infection, psychological counseling and harm reduction are provided by female staff. The aim of this study was to report the activities conducting in 2008. Registered information was used to assess the demographic characteristic, HIV/ AIDS related risk factors and services delivered to clients. Till March 2008, 442 clients have been admitted. Most of them (36.2%) had 25–34 years old. 14.3% were illiterate and 31% were totally jobless. The most prevalent risk factors were risky sexual behavior (27.1%) and non-injecting drug use (23.2%). Injecting drug use was detected in 11.3% of attendees. Dividing clients according to marital status, risky sexual behavior was the main risk factor in unmarried (40.2%) and divorced (26.9%) but in married and widow ones, non-injecting drug use was the most (25.8% and 36.5% respectively). Harm reduction (40.5%) and counseling (36.6%) were the most delivered services. Since vulnerable women play a critical role to spread HIV-epidemic to general population, increasing centers provide more access to this population.